LEADER 04312nam 2200541Ia 450 001 9910789898203321 005 20220525011458.0 010 $a1-61942-063-5 035 $a(CKB)2670000000135205 035 $a(EBL)3017783 035 $a(SSID)ssj0000686753 035 $a(PQKBManifestationID)12198992 035 $a(PQKBTitleCode)TC0000686753 035 $a(PQKBWorkID)10734369 035 $a(PQKB)10394603 035 $a(MiAaPQ)EBC3017783 035 $a(Au-PeEL)EBL3017783 035 $a(CaPaEBR)ebr10654754 035 $a(OCoLC)923653523 035 $a(EXLCZ)992670000000135205 100 $a20111206d2011 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aAcute kidney injury$b[electronic resource] $ecauses, diagnosis, and treatments /$fJonathan D. Mendoza, editor 210 $aNew York $cNova Biomedical/Nova Science Publishers$dc2011 215 $a1 online resource (200 p.) 225 1 $aNephrology research and clinical developments 300 $aDescription based upon print version of record. 311 $a1-61209-790-1 320 $aIncludes bibliographical references and index. 327 $aContents -- Preface -- How to Define and Classify Acute Kidney Injury (AKI): The "Risk Injury Failure Loss of Kidney Function End-Stage Kidney Disease" (RIFLE) and "Acute Kidney Injury Network" (AKIN) Classifications -- Abstract -- Introduction -- The Risk Injury Failure Loss of Kidney Function End-Stage Kidney Disease (RIFLE) Classification -- Validation of the RIFLE Criteria -- Hospitalized Patients -- ICU Patients -- Patients Undergoing Cardiac Surgery Patients Undergoing Aortic Arch Surgery -- Patients Undergoing Abdominal Aortic Surgery -- Chirrotic Patients -- Patients Submitted to Hepatic Transplantation -- Septic Patients -- Burn Patients -- Critically Ill Human Immunodeficiency Virus Infected Patients -- Trauma Patients -- Patients Receiving Hematopoietic Stem Cell Transplantation -- Strengths and Weaknesses of the RIFLE Classification -- Strengths of the RIFLE Classification -- Weaknesses of the RIFLE Classification -- The Acute Kidney Injury Network (AKIN) classification Strengths and Weaknesses of the AKIN Classification -- Strengths of the AKIN Classification -- Weaknesses of the AKIN Classification -- Which Classification Should We Use in Clinical Practice? -- References -- Acute Renal Failure in the Newborn (NB) -- Abstract -- Introduction -- Characteristics of the Kidney in the Newborn -- Acute Renal Impairment in Newborns -- Physiopathology -- Definition of AKI -- Diagnosis of AKI: Clinical and Laboratorial Aspects -- New Biomarkers -- Suggested Intervals for the Control of Renal Function Handling the IRA in the NB -- Prognosis of the NB with AKI -- Conclusion -- References -- Kidney Ischemia and Reperfusion Injury -- Abstract -- Kidney Ischemia and Reperfusion Injury -- Vascular Endothelial Cells -- Tubular Epithelial Cells -- Activation of Kidney Resident Cells and Kidney-Infiltrating Leukocytes -- T-Lymphocytes -- Increased Factors after IRI -- Adhesion Molecules -- Cytokines and Chemokines -- Hypoxia-Inducible Factor -- Toll-Like Receptors -- Changes in Renal Tissue after IRI FTY720 -- Modulates the Inflammatory Process after IRI (74) -- References -- Long-Term Prognostic Implication of Post-Angiographic Acute Kidney Injury and Hemodynamic Instability -- Abstract -- Introduction -- Post-Angiographic AKI -- Role of Hemodynamics in the Formation of Post-Angiographic AKI -- Lessons from Animal Models -- Role of Hemodynamics in the Incidence of Post-Angiographic AKI -- from the Clinical Points of Views -- Short-Term Prognosis of Post-Angiographic AKI -- Long-Term Prognosis and Post-Angiographic AKI: Role of Hemodynamics. 410 0$aNephrology research and clinical developments series. 606 $aAcute renal failure 606 $aKidneys$xDiseases 615 0$aAcute renal failure. 615 0$aKidneys$xDiseases. 676 $a616.6/14 701 $aMendoza$b Jonathan D$01584755 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910789898203321 996 $aAcute kidney injury$93868720 997 $aUNINA